Martin Dietrich, MD, PhD, separates an agent working in the brain from an agent acting on the brain, and explains that ...

Geoffrey Y. Ku, MD discusses two of the most active areas of investigation in the perioperative management of gastric and ...

Preview the 2026 International Myeloma Society meeting: the IMS/IMWG cure consensus, plenary session phase 3 trials, and new bispecific/CAR T myeloma findings. The 23rd International Myeloma Society ...

CAR T and bispecific T-cell engagers move earlier in blood cancer care, reshaping sequencing and expanding access beyond academic centers. T-cell–based immunotherapies have transformed the treatment ...

NCCN recommends rusfertide across PV risk strata as Category 1, uniquely spanning low- and high-risk disease in the updated ...

Martin Dietrich, MD, PhD, says he manages neurologic adverse events reactively rather than proactively, because he cannot ...